Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

NCT04395612 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: niraparib combined with brivanib
DRUG: niraparib combined with toripalimab

Sponsor

Chongqing University Cancer Hospital